Intratio
Loading...
Skip to main content
Model output · Signal date 2026-10-16

Clover Health Investments, Corp. /De (CLOV) Stock Forecast Oct. 16, 2026

Analysis updated on Oct. 16, 2026 (UTC) · Total · absolute moveSwitch to Alpha · Nasdaq

Follow Unlock full AI forecasts
Rating · 90D ▲ Bullish Exact rating locked
90-day forecast Sign up free to reveal
30-day forecast Total
Rank in coverage Top 35% of 5172 stocks scored
Rank correlation · 90D 16.0% Spearman, 357 dates
Market Cap $2.38B mid-cap · #8 of 10 peers
Summary

Clover Health Investments, Corp. /De (CLOV) stock forecast summary

Our AI ranks Clover Health Investments, Corp. /De outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.

Clover Health Investments, Corp. /De is a mid-cap company with a market capitalization of $2.38B. It ranks number 8 by market capitalization among the 10 Hospital & Medical Service Plans issuers in our coverage with a current forecast. Its D/E Ratio of 0.91x is the lowest of the 10 peers that report one.

For CLOV, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 16.0%, measured on 357 forecast dates between 2022-07-29 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 22.0%, measured on 400 forecast dates between 2022-07-29 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report

Expected absolute price move over the horizon, market included. This is the number a price target is built from. Ratings: strong buy ≥ +5.0%, buy ≥ +3.4%, sell < +1.8%, strong sell < +0.8% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-16 signals)

A free account shows the exact forecast, rating and rank of 3 tickers you follow, CLOV included.

Follow CLOV free
Price

CLOV price chart and AI forecast

CLOV
Cross-section · 2026-10-16

How CLOV ranks among 5172 stocks

90D Total forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).

Fundamentals · 2026-06-30

Clover Health Investments, Corp. /De (CLOV) fundamentals

Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Hospital & Medical Service Plans peers listed below that report each metric.

Valuation & Market

MetricCLOVIndustry medianRank
Market Cap $2.38B $22.49B 8/10
P/B Ratio 6.32x 2.84x 2/10
EPS $-0.10 – –
Book Value/Share $0.71 – –
Revenue/Share $4.66 – –
FCF/Share $0.14 – –

Profitability & Margins

MetricCLOVIndustry medianRank
ROIC -4.6% 6.9% 9/10
Operating Margin -0.7% 1.7% 9/10
EBT Margin -0.8% 1.4% 9/10

Financial Health

MetricCLOVIndustry medianRank
Current Ratio 1.50x 1.51x 6/10
D/E Ratio 0.91x 2.38x 10/10
Financial Leverage 1.91x 3.42x 10/10
Interest Coverage -4115.3x 7.5x 9/9
Working Capital $162M $580M 8/10

Cash Flow

MetricCLOVIndustry medianRank
Operating Cash Flow $77M $3.13B 10/10
Free Cash Flow $74M $1.27B 9/9
Capital Spending -$3M -$94M 1/9
FCF/Sales 3.0% 3.9% 7/9
CapEx/Sales 0.1% 0.4% 9/9

Operational Efficiency

MetricCLOVIndustry medianRank
Asset Turnover 3.44x 2.12x 2/10
Fixed Assets Turnover 342.5x 72.4x 1/10

Income Statement

MetricCLOVIndustry medianRank
Total Revenue $2.48B $90.86B 9/10
Operating Income -$18M $416M 9/10

Dividend & Shareholder Information

MetricCLOVIndustry medianRank
Shares Outstanding 531M – –

Balance Sheet Highlights (USD millions)

Total Current Assets$485M67.4% of assets
Cash & Short-term Investments$199M27.6% of assets
Total Liabilities$344M47.8% of assets
Quarterly Financial Reports

CLOV quarterly financials and insider trading

Industry Peers · Hospital & Medical Service Plans

Clover Health Investments, Corp. /De (CLOV) industry peers

Companies classified under the same SEC industry code as Clover Health Investments, Corp. /De (Hospital & Medical Service Plans): 10 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.

Reveal all forecasts · See exact % predictions for all competitors

Sign up free
Company 90-Day AI Forecast (Total) Market Cap P/E Ratio P/B Ratio
CLOV Clover Health Investments, Corp. /De ▲ $2.38B – 6.3x
UNH Unitedhealth Group Inc ▶ $360.32B 25.8x 3.7x
ELV Elevance Health, Inc. ▶ $92.88B 19.0x 2.1x
CI Cigna Group ▼ $79.88B 12.5x 1.9x
HUM Humana Inc ▶ $49.70B 44.1x 2.7x
CNC Centene Corp ▶ $34.16B – 1.5x
MOH Molina Healthcare, Inc. ▶ $10.82B – 2.6x
OSCR Oscar Health, Inc. ▲ $9.84B 22.0x 4.8x
ALHC Alignment Healthcare, Inc. ▲ $1.72B 82.8x 6.5x
TRUP Trupanion, Inc. ▼ $1.23B 72.1x 3.0x

Where CLOV sits on the market map

Finance · Hospital & Medical Service Plans
Explore the map →
News

Clover Health Investments, Corp. /De (CLOV) stock news

Loading...

FAQ

Clover Health Investments, Corp. /De (CLOV) stock forecast FAQ

What is the Clover Health Investments, Corp. /De (CLOV) stock forecast?

Our AI ranks Clover Health Investments, Corp. /De outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.

How accurate are Clover Health Investments, Corp. /De stock predictions?

For CLOV, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 16.0%, measured on 357 forecast dates between 2022-07-29 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 22.0%, measured on 400 forecast dates between 2022-07-29 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report

How often are Clover Health Investments, Corp. /De forecasts updated?

Clover Health Investments, Corp. /De forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 16, 2026.

Which companies are Clover Health Investments, Corp. /De's industry peers?

10 issuers in our coverage, CLOV included, share the SEC industry code Hospital & Medical Service Plans. The largest are: Unitedhealth Group Inc (UNH), Elevance Health, Inc. (ELV), Cigna Group (CI), Humana Inc (HUM), Centene Corp (CNC), Molina Healthcare, Inc. (MOH).

This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.